CD 5+ Peripheral B Cell Lymphoma With Transformation to CD 5+ Diffuse Large B Cell Lymphoma in the CNS: A Case Report Treated With Rituximab, High Dose Methotrexate, Cytarabine, and Intrathecal Methotrexate

B-cell non-Hodgkin’s lymphoma includes several subtypes, notably Diffuse Large B-Cell Lymphoma (DLBCL), the most common B-cell subtype. Each presentation has its defining characteristic, of which CD5 positivity is notoriously known for being a poor prognostic factor. CD5 positivity has a high female...

Descripción completa

Detalles Bibliográficos
Autores principales: Uczkowski, Dariusz, Apor, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308981/
https://www.ncbi.nlm.nih.gov/pubmed/35898806
http://dx.doi.org/10.7759/cureus.27201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308981/
https://www.ncbi.nlm.nih.gov/pubmed/35898806
http://dx.doi.org/10.7759/cureus.27201

Ejemplares similares